Medivir AB (OSTO:MVIR) Stock News, Headlines & Updates
Medivir AB Stock News from GuruFocus
- 1
Jun 28, 2024
Number of shares and votes in Medivir AB on 28 June 2024
PRNewswire • 5:00am
Jun 27, 2024
Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI
PRNewswire • 3:00am
Jun 19, 2024
Medivir selects global CRO partner for upcoming phase 2b study in HCC with fostrox + Lenvima and initiates study feasibility
PRNewswire • 4:00am
May 30, 2024
Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2024
PRNewswire • 6:00am
Medivir to present at Redeye Growth Day
PRNewswire • 3:00am
May 07, 2024
Resolutions at the Annual General Meeting in Medivir on 7 May 2024
PRNewswire • 9:00am
Apr 30, 2024
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024
PRNewswire • 3:00am
Apr 29, 2024
Medivir brings the Q1 webcast forward to 10 a.m. on April 30
PRNewswire • 5:00am
Apr 25, 2024
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
PRNewswire • 3:00am
Apr 23, 2024
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase 2b in HCC with fostrox + Lenvima continue
PRNewswire • 3:00am
Apr 15, 2024
Medivir's partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701
PRNewswire • 8:00am
Apr 09, 2024
Medivir to present at Investing in Oncology Forum on April 10
PRNewswire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news